Billy Wynne J.D.
Founder & Chairman
Billy Wynne is a nationally respected strategic advisor to elite health care organizations, including Fortune 500 companies, marquee health systems, and prominent foundations. After building one of Washington’s largest health policy practice, he and his team established the Wynne Health Group in January 2018, which became Impact Health Policy Partners in 2023.
Prior to his private sector career, Billy served as Health Policy Counsel to the Senate Finance Committee where he was a key drafter and negotiator of several health care laws and assisted in the development of the health care reform “White Papers” that served as the basis for the Affordable Care Act. He has published several dozen articles in Health Affairs and other platforms, often appears on cable news, and is frequently cited by the New York Times, Washington Post, Politico, and other publications.
Billy is also a social impact entrepreneur, having founded Policy Hub, the only comprehensive aggregator of federal health policy analysis, the Public Option Institute, which is dedicated to providing clear analysis of public option programs and recommending best practices, and Awake, Colorado’s first alcohol-free bar and spirit store.
Billy received a bachelor’s degree in Government from Dartmouth College and a law degree from the University of Virginia. He has served on several boards, including Operation Smile, Chinese Children Adoption International, and the Zen Center of Denver.
When he’s not working in Washington, Billy lives in Denver, CO with his wife, Christy, and their children, Eleanor and Lei.
E&C Health Members Discuss Aduhelm, Pandemics, Rare Diseases in FDA User Fee Reauthorization Hearing
On Feb. 3, 2022, the Subcommittee on Health of the House Committee on Energy & Commerce (E&C) convened a hearing on the reauthorization of three Food and Drug Administration (FDA) user fee programs (hearing memo). These include the seventh reauthorization of the Prescription Drug User Fee Act (PDUFA VII), the third reauthorization of the Generic…